Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...

An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Dementia is not one specific disease, but a general term used to describe the progressive loss of cognitive functions: ...

The new study included 75 outpatients with Alzheimer's dementia ... treat agitation in people with dementias. "While further analyses are needed to better understand predictors of treatment ...

Dementia is the biggest health challenge facing the UK ... In some people, though, they make no difference and cause side effects such as confusion and agitation.” Medication not specifically for ...

Kathy Richards, PhD, RN, FAAN, FAASM, of the University of Texas at Austin School of Nursing, presents cases of sleep disturbances in older adults at GAPNA 2024.

Dementia is not one specific disease, but a general term used to describe the progressive loss of cognitive functions: ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.